Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Onalabs

Explore full profile

Wearable devices for non-invasive biomarker monitoring

Barcelona, SpainFounded 2016Biotech & Life Sciences
Valuation $25–50M Last recorded · 2026
Revenue <$1M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Onalabs and the history behind them.

About Onalabs

Onalabs is a medical technology company founded in Barcelona, Spain, in December 2016 by Elisabet del Valle (CEO), Xavier Munoz (CSO), and Jordi Garriga. The founders' backgrounds are in science and patents, which has guided the company's focus on protecting its intellectual property. Del Valle, with a background in biochemistry, was driven by a fascination with life sciences to co-found the company. Onalabs has secured a total of $3.18 million in funding over seven rounds, including grants and seed funding. A notable seed round in October 2023 raised $1.9 million, led by FC Barcelona's Barça Innovation Hub (BIHUB), which became a strategic partner and shareholder.

Read full description

The company develops non-invasive, wearable medical devices that analyze biomarkers in sweat, effectively turning the skin into a data platform. Its business model includes both direct-to-consumer (B2C) sales and collaborations with distributors (B2B2C). The core technology is based on sensory bioengineering and uses disposable cartridges for sweat collection and analysis, which are connected to a mobile app and cloud platform. Onalabs holds the ISO 13485 certification for medical device quality management and a manufacturing license from the Spanish Agency of Medicines and Medical Devices (AEMPS).

Onalabs has three main products. ONASPORT is a chest strap device for athletes that measures lactate levels, electrolyte loss, dehydration, and heart rate in real-time to optimize training and prevent injuries. It has been tested with sports institutions like CAR Sant Cugat and INEFC-UB and is being further developed with FC Barcelona's athletes. The company launched its first physical retail point for ONASPORT in Andorra in February 2026. The second product, ONAVITAL, is designed for remote monitoring of chronic patients, tracking vital signs such as arterial pressure, oxygen saturation, and skin temperature. A third product, ONADM, is in the laboratory phase and aims to provide non-invasive, continuous glucose monitoring for diabetic patients.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2016
Headquarters
Barcelona, Spain
Employees
33
Open positions
1
Dealroom signal
86.7/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotech & Life Sciences, Biotechnology, Biomarkers, Point of Care, Remote Monitoring, Telemedicine, Molecular Biology
Technology
Hardware, Nanotech, Autonomous & Sensor Tech
Business model
Manufacturing
Client focus
b2b

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SEEDOther financing Jul 2026 $10M $41M NPrime Partners Capital · WA4STEAM · Ninteen Twenty-One · SETT ↗
SEEDOther financing Oct 2023 $2M $7.9M Barca Innovation Hub ↗
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Onalabs website traffic

Latest recorded traffic for Onalabs is 4.4K monthly website visits, up 41.9% over the last three months. Onalabs's team grew 13.8% over the past year.

Latest monthly visits4.4K 3-month web change+41.9% 1-year team growth+13.8%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed8 investors entered at this stage

  • European Innovation Council
  • Capital Cell
  • Barca Innovation Hub
  • NPrime Partners Capital
  • WA4STEAM
  • Ninteen Twenty-One
  • SETT
  • Reig Patrimonia

Other known investors3 additional known investors

  • EIT Health
  • Esade Ban
  • Marta Huidobro
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇪🇸 Spain96.3%
🏳️ Andorra3.7%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Onalabs on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Onalabs’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.